157
Participants
Start Date
August 31, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
ABT-126
ABT-126 Low Dose
ABT-126
ABT-126 High Dose
Placebo
Placebo
Site Reference ID/Investigator# 73982, New York
Site Reference ID/Investigator# 72700, Cedarhurst
Site Reference ID/Investigator# 75654, Atlanta
Site Reference ID/Investigator# 75146, Maitland
Site Reference ID/Investigator# 75314, Bradenton
Site Reference ID/Investigator# 76534, Hoffman Estates
Site Reference ID/Investigator# 72703, Chicago
Site Reference ID/Investigator# 73981, St Louis
Site Reference ID/Investigator# 73984, Lake Charles
Site Reference ID/Investigator# 113035, Oklahoma City
Site Reference ID/Investigator# 72702, DeSoto
Site Reference ID/Investigator# 75147, Houston
Site Reference ID/Investigator# 72701, Torrance
Site Reference ID/Investigator# 74436, Chino
Site Reference ID/Investigator# 72699, National City
Site Reference ID/Investigator# 73983, Oceanside
Site Reference ID/Investigator# 86974, San Diego
Site Reference ID/Investigator# 72704, Garden Grove
Site Reference ID/Investigator# 73236, Orange
Site Reference ID/Investigator# 89553, Marlton
AbbVie (prior sponsor, Abbott)
INDUSTRY